Skip to main content
Cancer Biotherapy & Radiopharmaceuticals logoLink to Cancer Biotherapy & Radiopharmaceuticals
. 2023 May 11;38(4):273. doi: 10.1089/cbr.2022.0056.correx

Correction to: Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan, by Matsumura, et al. Cancer Biotherapy and Radiopharmaceuticals 2023;38(3):201–207; doi: 10.1089/cbr.2022.0056

PMCID: PMC10325803  PMID: 37172293

In the April 2023 issue of Cancer Biotherapy and Radiopharmaceuticals (vol. 38, no. 3; pp. 201–207), the article entitled “Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan” by Matsumura, et al. requires correction.

This article was originally published under the copyright of Mary Ann Liebert, Inc. publishers. It has now been updated to reflect Open Access, with copyright transferring to the author(s), and a Creative Commons License (CC-BY) added (http://creativecommons.org/licenses/by/4.0). The CC-BY license goes into effect April 28, 2023.

The online version of this article has been corrected to reflect this.


Articles from Cancer Biotherapy & Radiopharmaceuticals are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES